IP Library Granted Patent US 9,446,025
Granted Patent B2
US 9,446,025 · App. 14/738,717 · Granted Sep 20, 2016

Treatment or prevention of hypotension and shock

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,446,025
App. No.
14/738,717
Granted
Sep 20, 2016
Kind
B2
Abstract

The present invention relates to a method for the prevention and treatment of hypotension and shock due to low peripheral resistance, comprising administering to a mammal in need thereof an effective amount of a certain imidazole derivative or pharmaceutically acceptable ester or salt thereof. In addition, the present invention relates to a method for the treatment of cardiopulmonary resuscitation, comprising administering to a mammal in need thereof an effective amount of a certain imidazole derivative or pharmaceutically acceptable ester or salt thereof.

Claims (4)

1. A method for the treatment of hypotension and shock due to low peripheral resistance, comprising intravenously administering to a human in need thereof about 10-500 μg/patient of an imidazole derivative of formula I:

wherein R is hydrogen or methyl, or hydrochloride salt thereof.

2. The method according to claim 1 , wherein 3-(1H-imidazol-4-ylmethyl)-indan-5-ol is administered.

3. The method according to claim 1 , wherein the effective amount administered is about 30-200 μg/patient.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Dec 16, 2022
From: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
To: SOCIETAL CDMO, INC.
Reel/Frame 062123/0184 →
SECURITY INTEREST Recorded Jun 10, 2020
From: BAUDAX BIO N.A. LLC; BAUDAX BIO LIMITED; BAUDAX BIO, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 052891/0590 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2020
From: RECRO PHARMA, INC.
To: BAUDAX BIO, INC.
Reel/Frame 051671/0536 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED AT REEL: 044166 FRAME: 0008. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Mar 8, 2019
From: RECRO PHARMA, INC.
To: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
Reel/Frame 048540/0415 →
SECURITY INTEREST Recorded Nov 17, 2017
From: RECRO PHARMA, INC.
To: ATHYRIUM OPPORTUNITIES III ACQUSITION LP
Reel/Frame 044166/0008 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2015
From: HEINO, RIITTA; LEINO, TIINA; LEHTIMAKI, TARJA
To: ORION CORPORATION
Reel/Frame 037054/0614 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2015
From: ORION CORPORATION
To: RECROPHARMA, INC.
Reel/Frame 037054/0708 →